Black Diamond Ventures

What Black Diamond Ventures does

Black Diamond Ventures (BDV) is a privately held venture capital firm founded in 2000 by Christopher B. Lucas and headquartered in Glendale, California, with a second office in Los Gatos (Silicon Valley). The firm invests opportunistically in Series B, later-stage, and growth capital rounds in biotech, deep tech, and med tech companies, deploying $2MM to $10MM in initial and follow-on investments. BDV structures its offering as a fund vehicle open to individual accredited investors (minimum $500K), family offices (minimum $1MM), and institutional investors (minimum $2MM), generating returns through carried interest and management fees. Its current portfolio spans biomanufacturing (Lyric Bio), in vivo therapeutics (ImmunoVec), AI-driven gaming (Operative Games), enterprise AI platforms (App Orchid), and AI/robotics-enabled materials (Ares Materials).

BDV differentiates through its operating partner network: John Kispert (former Spansion CEO, ex-KLA-Tencor COO/CFO) leads the Silicon Valley office; Jon Kraft (Pandora co-founder, UberMedia COO) contributes consumer and software expertise; David Lynch (CEO of Koneksa Health, ex-CEO of Strateos) covers digital health and life sciences; Darryl Wash brings four decades of investment banking and venture experience; and Managing Partner Ana Quintana drives portfolio company engagement on communications, capital raising, and marketing. This bench supports BDV's stated value proposition of providing tactical, one-on-one strategic and operational guidance alongside capital.

The firm reports a multi-cycle performance record including exits of DexCom (IPO as DXCM), DivX Networks, Khimetrics (acquired by SAP), and Fore10 Network (acquired by Dell). BDV markets primarily through its website, LinkedIn, and direct network outreach to founders and LPs. Revenue, AUM, and fund size are not publicly disclosed, and the firm operates with a compact team of approximately seven members.

Name

Black Diamond Ventures

Legal name

Black Diamond Ventures

Website

https://bdventures.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

1–10 employees

Short description

Black Diamond Ventures is a privately held venture capital firm founded in 2000 that deploys $2MM-$10MM into Series B and growth-stage biotech, deep tech, and med tech companies, serving accredited investors, family offices, and institutional LPs.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

All Other Financial Investment Activities (52399), Portfolio Management and Investment Advice (52394), Other Investment Pools and Funds (5259)

SIC

Investment Advice (6282)

akta.pro primary industry

Business Services (B2B) Growth Equity (FSANACAD)

Keywords

• Venture capital
• Growth equity investing
• Series B investing
• Biotech venture capital
• Deep tech investment

Headquarters

HQ city

Glendale

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Venture Capital Returns: As a venture capital firm, BDV generates returns through carried interest and management fees from their investment fund. They invest in portfolio companies and realize returns through exits (IPOs or acquisitions) such as past successes including DexCom, DivX Networks, Khimetrics, and Fore10 Network.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Black Diamond Ventures is a venture capital firm that deploys multi-stage capital ($2MM to $10MM per investment) into Series B, later-stage, and growth-stage companies developing transformative technologies in biotech, deep tech, and med tech. The firm pools capital from accredited individuals, family offices, and institutional investors (minimums ranging from $500K to $2MM) and supports portfolio companies with strategic guidance, operational support, and introductions through its partner network.

Product overview

Black Diamond Ventures is a transformational venture capital firm providing multi-stage investment services to visionary founders. Rather than a unified software product, BDV offers a portfolio of investment offerings targeting Series B, later stage, and growth capital investments ranging from $2MM to $10MM. The firm focuses on the biotech, deep tech, and med tech sectors, including verticals in AI, big data, ML, materials science, and semiconductors. BDV supports its portfolio companies through strategic and operational guidance from its network of partners. The portfolio ecosystem includes Lyric Bio (biomanufacturing), ImmunoVec (in vivo therapies), Operative Games (AI-powered gaming), App Orchid (enterprise AI platform), and Ares Materials (AI-driven materials science).

Differentiator

Problem solved

Functional benefit

Products and services

• Multi-Stage Venture Capital Investment Fund Opportunistic multi-stage investment fund providing $2MM to $10MM of initial and follow-on capital to visionary founders in biotech, deep tech, and med tech sectors, paired with strategic and operational support from a partner network.
• Limited Partner Investment Program Structured fund participation vehicle for accredited individual investors, family offices, and institutional investors seeking access to invest alongside first-tier VC firms in privately-held companies, with minimum commitments ranging from $500,000 to $2,000,000 depending on investor type.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• ARTIS Ventures: ARTIS Ventures is a deep tech and biotech-focused venture firm investing across similar stages (Series B and growth) in Silicon Valley, with comparable thesis-driven approach to frontier science investments.
• DCVC (Data Collective): DCVC is a deep tech venture firm investing in Series B and later-stage rounds in computationally-driven and biotech-enabled companies, sharing BDV's later-stage, deep-tech thesis.
• Fifty Years: Fifty Years is a deep tech-focused VC that invests in founders building technology with the potential for outsized impact — directly comparable to BDV's biotech/deep tech mandate and similar check size range.
• Civilization Ventures: Civilization Ventures is a biotech and health-focused VC investing across stages in breakthrough science companies, with an investment thesis closely mirroring BDV's biotech/med tech focus.

Broad incumbents

• Lux Capital: Lux Capital is an established deep tech and science-focused VC investing in biotech, semiconductors, and frontier technology at similar stages — a broader incumbent with overlapping deal flow in the same sectors as BDV.
• ARCH Venture Partners: ARCH is one of the largest biotech-focused venture firms, investing across all stages of company formation in life sciences — a broad incumbent that competes with BDV for biotech and med tech deals.
• Khosla Ventures: Khosla Ventures is a major deep tech and biotech investor covering early through growth stages, competing with BDV for similar founders across biotech, deep tech, and med tech.
• Section 32: Section 32 is a biotech and healthtech-focused venture firm founded by Bill Maris, investing at growth stages in life sciences companies that overlap with BDV's biotech/med tech portfolio.
• Founders Fund: Founders Fund is a long-tenured, California-based venture firm investing across stages in deep tech and biotech, sharing BDV's later-stage approach and California base of operations.

Emerging players

• Innovation Endeavors: Innovation Endeavors is a deep tech and biotech VC firm investing in Series B and growth-stage companies, increasingly competing with BDV for founders in frontier science and AI-driven biotech.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/bdventures1
• LinkedInlinkedin.com/company/black-diamond-ventures

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments28 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Black Diamond Ventures